Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
Arch Pediatr ; 25(6): 383-388, 2018 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-30041886

RESUMEN

OBJECTIVES: Mortality rates of very preterm infants may vary considerably between healthcare facilities depending on the neonates' place of inclusion in the cohort study. The objective of this study was to compare the mortality rates of live-born extremely preterm neonates observed in two French tertiary referral hospitals, taking into account the occurrence of neonatal death both in the delivery room and in the neonatal intensive care unit (NICU). METHODS: Retrospective observational study including all pregnancy terminations, stillbirths and live-born infants within a 22- to 26-week 0/6 gestational age range was registered by two French level 3 university centers between 2009 and 2013. The mortality rates were compared between the two centers according to two places of inclusion: either the delivery room or the NICU. RESULTS: A total of 344 infants were born at center A and 160 infants were born at center B. Among the live-born neonates, the rates of neonatal death were similar in center A (54/125, 43.2%) and center B (33/69, 47.8%; P=0.54). However, neonatal death occurred significantly more often in the delivery room at center A (31/54, 57.4%) than at center B (6/33, 18.2%; P<0.001). Finally, the neonatal death rate of live-born very preterm neonates admitted to the NICU was significantly lower in center A (25/94, 26.6%) than in center B (27/63, 42.9%; P=0.03). CONCLUSIONS: This study points out how the inclusion of deaths in the delivery room when comparing neonatal death rates can lead to a substantial bias in benchmarking studies. Center A and center B each endorsed one of the two models of preferential place of neonatal death (delivery room or NICU) detailed in European studies. The reasons behind the two different models and their impact on how parents perceive supporting their neonate need further investigation.


Asunto(s)
Salas de Parto/estadística & datos numéricos , Mortalidad Infantil , Unidades de Cuidado Intensivo Neonatal/estadística & datos numéricos , Femenino , Francia , Humanos , Lactante , Recien Nacido Extremadamente Prematuro , Recién Nacido , Embarazo , Sistema de Registros , Estudios Retrospectivos , Centros de Atención Terciaria/estadística & datos numéricos
2.
Ann Dermatol Venereol ; 142(5): 346-9, 2015 May.
Artículo en Francés | MEDLINE | ID: mdl-25683012

RESUMEN

BACKGROUND: Dystrophic epidermolysis bullosa (DEB) is a genodermatosis characterized by various abnormalities of anchoring fibrils, composed mainly of type VII collagen, at the dermal-epidermal junction. These changes are induced by mutations in the type VII collagen gene (COL7A1). PATIENTS AND METHODS: A new-born boy was diagnosed with recessive DEB on the basis of typical skin lesions composed of multiple blisters with erosions on trauma-exposed body sites, including the hands and feet and the navel. Diagnosis was confirmed by pathology examination and irregular immunofluorescence staining of type VII collagen. Genomic DNA from the patient and parents were subjected to direct sequencing for the COL7A1 gene. Two heterozygous mutations were detected in the affected child. Each parent was a carrier of one heterozygous mutation. DISCUSSION: Over 730 mutations of the COL7A1 gene have been identified as responsible for phenotypic polymorphism of EBD. The relatively mild phenotype seen in our patient, known as "non-Hallopeau-Siemens" or "mitis" EBD, is due to residual synthesis of collagen VII. The mutation present on the maternal allele that prevents synthesis of collagen VII is compensated by the mutation on the paternal allele, which enables more or less functional collagen VII synthesis.


Asunto(s)
Colágeno Tipo VII/genética , Epidermólisis Ampollosa Distrófica/genética , Heterocigoto , Mutación , Humanos , Recién Nacido , Masculino
4.
Eur J Clin Nutr ; 65(10): 1088-93, 2011 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-21587281

RESUMEN

BACKGROUND/OBJECTIVES: Recent guidelines for preterm parenteral nutrition (PN) recommend an earlier and higher intake of amino acids (AA) and energy to avoid postnatal catabolism and approximate normal fetal growth. Few investigations explored how early PN may affect electrolyte and water homeostasis. We performed a prospective observational trial to assess the effect of nutrient intake on electrolyte homeostasis and balance. SUBJECTS/METHODS: During 16 months, all infants ≤32 weeks were eligible. In the first week of life, we recorded the following daily: electrolytes (plasma and 8-h urine collection), nutritional intake, urine output, body weight, and we calculated sodium (Na) and potassium (K) balance. Infants were divided, for analysis, into three groups of AA intake: low <1.5 g/kg/day (LAA), medium 1.5-2 g/kg/day (MAA) and high >2 g/kg/day (HAA). RESULTS: A total of 154 infants were included. HAA group presented lower weight loss. Na balance was influenced by urine output and postnatal age, with little contribution of nutrition. Kalemia and K balance were mainly influenced by AA intake. K balance differed among groups: LAA, -2.3 mmol/kg/week; MAA, 1.1 mmol/kg/week; and HAA 2.6 mmol/kg/week (P<0.0001). In the HAA group, plasma and urine K were significantly lower and non-oliguric hyperkalemia was reduced. CONCLUSIONS: Na homeostasis was very slightly modified by early nutrition, suggesting that a negative Na balance is obligatory after birth. We showed that AA intake strongly affects K balance, minimize hyperkalemia and reduces weight loss. As K balance is strictly linked to cellular metabolism, we speculate that early nutrition may inhibit cellular catabolism and reduce the contraction of intracellular water compartment.


Asunto(s)
Ingestión de Energía , Recien Nacido Prematuro/metabolismo , Nitrógeno/administración & dosificación , Nutrición Parenteral/normas , Equilibrio Hidroelectrolítico , Aminoácidos/administración & dosificación , Electrólitos/sangre , Electrólitos/orina , Homeostasis/efectos de los fármacos , Humanos , Hiperpotasemia/fisiopatología , Hiperpotasemia/prevención & control , Lactante , Recién Nacido , Modelos Lineales , Análisis Multivariante , Potasio en la Dieta/administración & dosificación , Potasio en la Dieta/metabolismo , Estudios Prospectivos , Sodio en la Dieta/administración & dosificación , Sodio en la Dieta/metabolismo , Pérdida de Peso/efectos de los fármacos
5.
Rev Neurol (Paris) ; 165(11): 889-900, 2009 Nov.
Artículo en Francés | MEDLINE | ID: mdl-19282014

RESUMEN

The clinical presentation, risk factors, causes, vital or functional prognosis, and acute management options for stroke occurring in neonates and children are specific, differing from those observed in young adults. Compared with the adult population, less is known about the epidemiology of stroke in the under-18 population where the disease could become more frequent because of advances in both neonatal resuscitation techniques for cerebral disorders and neuroimaging techniques enabling the diagnosis of small lesions. Clinical features are often delayed, especially in neonates, and unlike epilepsy or dystonia of the affected limb, which are frequent complications, aphasia is rather rare. The most frequent causes of stroke at the beginning of life are cardiac embolism, for ischemic stroke, and arteriovenous malformations, for intracerebral hemorrhage. Acute management at this age is specific. This article reviews the literature on the epidemiological and clinical features, the main causes, and the acute management guidelines of stroke occurring in newborn infants and children and highlights the need for neurologists to have comprehensive knowledge of this disease.


Asunto(s)
Enfermedades del Recién Nacido/epidemiología , Accidente Cerebrovascular/epidemiología , Enfermedad Aguda , Niño , Humanos , Recién Nacido , Enfermedades del Recién Nacido/terapia , Guías de Práctica Clínica como Asunto , Pronóstico , Factores de Riesgo , Accidente Cerebrovascular/terapia
6.
Gynecol Obstet Fertil ; 37(2): 115-24, 2009 Feb.
Artículo en Francés | MEDLINE | ID: mdl-19200766

RESUMEN

OBJECTIVE: A fetal megacystis is defined by a longitudinal bladder diameter more than 7 mm. The purpose of this study is to describe the prenatal ultrasound findings of this early fetal pathology and to assess pronostic and aetiologycal criteria. PATIENTS AND METHODS: Between January 2003 and December 2008, 12 cases of early fetal megacystis were identified in our referral fetal medicine unit (Saint-Etienne hospital, France). RESULTS: There were two cases of spontaneous resolution and one case wasn't a fetal megacystis. Termination of pregnancy for medical indications was realised for another cases because of associated malformations and bad evolution (six cases) and three chromosomal abnormalities (two cases of trisomy 18 and one of trisomy 21). DISCUSSION AND CONCLUSION: Sonographic follow-up and fetal karyotyping are important to evaluate prognosis. However, our data suggest that fetal megacystis is a severe condition when diagnosed in early pregnancy.


Asunto(s)
Aborto Inducido , Primer Trimestre del Embarazo , Ultrasonografía Prenatal/métodos , Vejiga Urinaria/anomalías , Vejiga Urinaria/diagnóstico por imagen , Adulto , Aberraciones Cromosómicas , Femenino , Edad Gestacional , Humanos , Cariotipificación , Embarazo , Resultado del Embarazo , Pronóstico , Estudios Retrospectivos , Factores de Riesgo , Trisomía
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA